| Terminated | Safety, PK, PD, and Antitumor Activity of Vecabrutinib (SNS-062) in B Lymphoid Cancers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Lymphoplasmacytoid Lymphoma | Phase 1 / Phase 2 | 2017-04-28 |
| Completed | Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory AML Acute Myeloid Leukemia | Phase 3 | 2010-12-17 |
| Completed | Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia Leukemia, Acute Disease, Acute Myeloid Leukemia | Phase 2 | 2008-05-15 |
| Completed | Safety and Tolerability Study of Voreloxin and Cytarabine Combination in Acute Myeloid Leukemia in Humans Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2007-10-06 |
| Completed | Safety and Tolerability Study of SNS-314 for Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2007-08-01 |
| Completed | Study of Intravenously Administered SNS-032 in Patients With Advanced B-lymphoid Malignancies B-lymphoid Malignancies, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma | Phase 1 | 2007-02-01 |
| Completed | Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer Epithelial Ovarian Cancer | Phase 2 | 2006-12-20 |
| Completed | Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer Carcinoma, Small Cell, Small Cell Lung Cancer | Phase 2 | 2006-02-01 |
| Completed | Safety Assessment of One-hour Infusions of SNS-032 for the Treatment of Select Advanced Solid Tumors Tumors | Phase 1 | 2006-01-01 |
| Completed | Safety and Efficacy Clinical Study of SNS-595 for Second-Line Therapy in Patients With Advanced NSCLC Carcinoma, Non-Small-Cell Lung | Phase 2 | 2005-12-27 |
| Completed | Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malign Leukemia, Lymphocytic, Acute, Leukemia, Nonlymphocytic, Acute, Leukemia, Myeloid, Chronic | Phase 1 | 2005-11-14 |
| Completed | Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors Neoplasms | Phase 1 | 2004-10-01 |
| Completed | Initial Safety Assessment of SNS-595 for the Treatment of Solid Tumors. Neoplasms | Phase 1 | 2004-06-01 |